Essential Medicines for Noncommunicable Diseases Available through the PAHO Strategic Fund
| dc.date.accessioned | 2021 | |
| dc.date.available | 2021 | |
| dc.date.issued | 2021 | |
| dc.identifier.govdoc | PAHO/NMH/MH/21-0033 | |
| dc.identifier.uri | https://iris.paho.org/handle/10665.2/55092 | |
| dc.description.abstract | The Pan American Health Organization’s Revolving Fund for Strategic Public Health Supplies (Strategic Fund) helps ensure the availability of essential medicines for noncommunicable diseases, including palliative care medicines, at a competitive price for all countries. The Strategic Fund is an integrated pooled procurement mechanism, and the products purchased through the Strategic Fund meet international standards in safety, efficacy, and quality. This brochure presents information on the medications and their formulations available through the Strategic Fund for noncommunicable diseases, summarized by category: cardiovascular diseases, diabetes, cancer, chronic respiratory diseases, and palliative care. The brochure includes examples of price reductions achieved by the Strategic Fund for key essential medicines, ensuring competitive prices for these for Latin America and the Caribbean. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | PAHO | en_US |
| dc.rights | Attribution-NonCommercial-ShareAlike 3.0 IGO | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/igo/ | * |
| dc.subject | Noncommunicable Diseases | en_US |
| dc.subject | Medicine | en_US |
| dc.subject | Access to Essential Medicines and Health Technologies | en_US |
| dc.subject | Palliative Care | en_US |
| dc.subject | Cardiovascular Diseases | en_US |
| dc.subject | Diabetes Mellitus | en_US |
| dc.subject | Neoplasms | en_US |
| dc.subject | Respiratory Tract Diseases | en_US |
| dc.subject | Drugs, Essential | en_US |
| dc.title | Essential Medicines for Noncommunicable Diseases Available through the PAHO Strategic Fund | en_US |
| dc.type | Information kit (folder, banner, brochure) | en_US |
| dc.rights.holder | Pan American Health Organization | en_US |
| dc.contributor.corporatename | Pan American Health Organization | en_US |
| paho.isfeatured | 0 | en_US |
| paho.publisher.country | United States | en_US |
| paho.publisher.city | Washington, D.C. | en_US |
| paho.source.centercode | US1.1 | en_US |
| paho.relation.languageVersion | 10665.2/55093 | |
| paho.contributor.department | Noncommunicable Diseases and Mental Health (NMH) | en_US |
| paho.iswhotranslation | No | en_US |
Arquivos deste item
Este item aparece na(s) seguinte(s) coleção(s)
Este aviso deve ser preservado juntamente com o URL original do artigo.Attribution-NonCommercial-ShareAlike 3.0 IGO
Itens relacionados
Apresentado os itens relacionados pelo título, autor e assunto.
-
(PAHOUnited StatesWashington, D.C, 2013)Executive Summary The inaugural meeting of the Expert Committee for the Selection and Inclusion of Medicines in the Pan American Health Organization Strategic Fund was held at the Headquarters of the Pan American Health ...
-
(PAHOUnited StatesWashington, D.C., 2020)In 2000, the Pan American Health Organization (PAHO) established the Strategic Fund to improve access to safe, efficacious, and high-quality medicines and other health supplies. This increased access would inevitably ...
-
(PAHOUnited StatesWashington, D.C, 2016)The PAHO Regional Revolving Fund for Strategic Public Health Supplies (hereinafterreferred to as the PAHO Strategic Fund or the Strategic Fund), was created in 1999 by the then Director of PAHO at the request of Member ...
